Populations who use long-term services and supports (LTSS) are particularly vulnerable to contracting COVID-19 and experiencing severe cases due to their age or because they are living with one or more chronic conditions.
The nation’s nursing homes, assisted-living facilities, inpatient rehabilitation centers and home care providers are at the forefront of the COVID-19 crisis.
On Monday, the Centers for Medicare & Medicaid Services (CMS) released an interim final rule with comment period outlining new flexibilities to pre-existing Medicare and Medicaid payment policies and provider regulations in the midst of the COVID-19 public health emergency (PHE).
The nation’s nursing facilities, assisted-living facilities, inpatient rehabilitation facilities and home care providers—and their long-term care (LTC) workforce—are at the forefront of the COVID-19 crisis.
On March 27, Congress passed a third stimulus package in response to COVID-19—H.R. 748, the Coronavirus Aid, Relief, and Economic Security Act (CARES Act).
On Sunday, March 22, the Centers for Medicare & Medicaid Services (CMS) released a suite of tools to help state Medicaid and Children’s Health Insurance Program (CHIP) agencies respond to the COVID-19 pandemic.
Editor’s Note: Dual eligibles—those eligible for both Medicare and Medicaid—are among the most costly and complex enrollees in both programs.
Dual eligibles are an exceedingly high-need, high-cost population.
Dual eligibles—those eligible for both Medicare and Medicaid—are among the most costly and complex enrollees in both programs.
In early 2017, California Assembly member Jim Wood introduced Bill AB-265, banning the use of copay coupons in California when a generic equivalent drug covered by an individual’s health plan exists.